Clinical Trial Update: Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion [Phase 4]

View source ↗

Summary

Phase 4 trial assessed the relevance of heparin/platelet factor 4 antibodies on vein graft patency after coronary bypass surgery and explored Argatroban for pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heparin-induced Thrombocytopenia

Drugs mentioned

• Argatroban (argatroban)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Coronary Artery Bypass Graft Surgery, Presence of Heparin/Platelet Factor 4 Antibody | Phase 4 | Status: TERMINATED | Results posted: 2012-03-12